Study guide

12.1 Pulmonic Regurgitation Mechanism and Severity

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

12.1 Pulmonic Regurgitation Mechanism and Severity

Key Takeaways Explain This Topic AI

Separate primary pulmonic regurgitation caused by abnormal cusps or prior intervention from secondary regurgitation caused by pulmonary hypertension and annular or pulmonary-artery dilation.

Severe primary PR may be low velocity, laminar, brief, and visually unimpressive because pulmonary-artery and RV diastolic pressures equalize rapidly; color jet length or peak velocity alone is unreliable.

Integrate jet origin and width, CW density and deceleration, branch pulmonary-artery flow reversal, RV size and function, septal motion, and loading conditions rather than treating one cutoff as the grade.

Use CMR when significant PR is suspected but TTE is incomplete or discordant, particularly after congenital repair, because it directly quantifies regurgitant fraction and provides reproducible RV volumes.

Last updated: July 2026

Define mechanism before measuring the jet

CCI task C12 is to assess pulmonic regurgitation (PR). Trace or mild PR is common in otherwise normal adults and usually physiologic. More-than-mild PR requires a mechanism. Primary PR reflects abnormal cusp tissue or direct valve disruption, most often congenital disease, repaired tetralogy of Fallot, surgical RVOT reconstruction, or prior balloon valvuloplasty. Less common causes include endocarditis, carcinoid retraction, rheumatic disease, trauma, and iatrogenic injury. Describe absent, dysplastic, thickened, retracted, prolapsing, perforated, or postintervention tissue when demonstrated.

In secondary PR , the cusps are not the primary lesion. Pulmonary hypertension and dilation of the main pulmonary artery or annulus prevent effective diastolic coaptation. Secondary PR is often high velocity and holodiastolic because PA pressure remains high, yet its regurgitant volume is commonly modest. In contrast, severe primary PR with normal PA pressure may be low velocity, laminar, and very brief because PA and RV diastolic pressures equalize rapidly. A short, faint-looking color jet is therefore not automatically mild.

Obtain parasternal short-axis RVOT, modified RVOT, high parasternal, and subcostal views. Sweep through the valve, annulus, RVOT, main PA, and proximal branches. Optimize color gain and use a Nyquist limit near 50–70 cm/s for standard comparison, then adjust when low-velocity flow is being missed. Document jet origin, multiplicity, direction, and relation to the annulus. PW mapping can distinguish valvar flow from conduit or branch obstruction, while CW should be aligned through the regurgitant jet from the best window.

Build mutually checking severity evidence

The proximal color-jet width or vena contracta is more useful than distal jet area or length. Measure immediately below the valve in early diastole and compare with the pulmonary annulus in the same plane. A broad origin occupying at least about 70% of annular width is a specific severe-pattern sign in native PR, but eccentricity, multiple jets, oblique imaging, gain, and scale can distort the ratio. A narrow jet shorter than about 10 mm supports trivial or mild PR only when the driving pressure and remaining findings agree.

Evidence Severe-pattern finding Critical limitation

Color origin Broad vena contracta or jet-width/annulus ratio around 70% or more Oblique, eccentric, multiple, or low-velocity jets

CW density Dense regurgitant envelope Central alignment can make a lesser jet appear dense

CW timing Rapid deceleration and early diastolic termination High RV diastolic pressure or low RV compliance causes rapid equalization

Branch PA PW Prominent diastolic flow reversal Brief early reversal can be normal; main PA alone is less specific

RV response Chronic RV/RVOT dilation with volume-overload septal motion Congenital repair, shunt, or TR can enlarge the RV independently

A pressure half-time below 100 ms, deceleration time below 260 ms, or PR index below 0.77 supports important PR but is not diagnostic alone. The PR index equals PR duration divided by total diastolic duration. Each index reflects the rate or timing of PA–RV pressure equalization and changes with RV compliance, RV end-diastolic pressure, pulmonary pressure, heart rate, and Doppler alignment. Report premature termination rather than converting an incomplete or poorly aligned envelope into a precise measurement.

Sample both right and left branch PAs when feasible. Prominent diastolic reversal in a branch is more specific for severe PR than reversal confined to the main PA; brief early-diastolic reversal is not sufficient. Record forward RVOT/PV flow as well, since markedly greater pulmonic than systemic stroke volume can support regurgitant volume overload when no shunt or other important regurgitation invalidates the comparison.

Quantitative Doppler estimates PR regurgitant volume = RVOT stroke volume − systemic forward stroke volume and regurgitant fraction = PR regurgitant volume / RVOT stroke volume . It is vulnerable to the squared RVOT-diameter error, noncircular geometry, mismatched sample locations and beats, shunts, and other valve regurgitation. EROA is not well validated for PR. A regurgitant fraction below 20%, 20%–40%, or above 40% is commonly used to support mild, moderate, or severe PR, respectively, but the evidence is largely CMR based and does not make Doppler quantitation definitive.

Interpret the right ventricle in context

Use a comprehensive current right-heart examination: an RV-focused apical view, basal and mid dimensions, RV end-diastolic and end-systolic areas, fractional area change, TAPSE, tissue Doppler S′, and additional function measures when feasible. Assess RA size, IVC, TR, estimated pulmonary pressure, RVOT size, and septal shape. Chronic severe primary PR almost always produces RV dilation, initially with preserved function and a diastolic volume-overload pattern; progressive dysfunction may follow. A normal RV argues against chronic severe primary PR unless the lesion is acute. RV enlargement after congenital repair may predate or exceed the current PR burden, while secondary PR in pulmonary hypertension may coexist with pressure-overload remodeling.

If most independent findings are mild or severe and technically valid, classification is confident. Mixed or intermediate findings usually support moderate PR, but unexplained discordance should remain indeterminate. Recheck color settings, jet alignment, branch sampling, RV measurements, rhythm, pulmonary pressure, and prior surgery. CMR directly measures pulmonary forward and reverse flow and is preferred for PR fraction and RV volumes when TTE is incomplete, when the RV enlarges despite an apparently moderate jet, or when congenital intervention is being considered. Communicate suspected vegetation, acute severe PR, conduit complication, or rapid RV deterioration promptly.